New drug hopes to tame hardening skin disease
Disease control
Terminated
This study tests a new drug called CM-101 for people with systemic sclerosis, a disease that causes skin hardening and organ damage. About 45 adults will receive either the drug or a placebo to check safety and how well the body tolerates it. The goal is to see if CM-101 can redu…
Phase: PHASE2 • Sponsor: ChemomAb Ltd. • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC